Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1984 3
1985 2
1986 3
1987 2
1988 3
1989 3
1990 2
1991 4
1992 5
1993 3
1994 3
1995 5
1996 1
1997 4
1998 4
1999 1
2000 8
2001 6
2002 4
2003 7
2004 4
2005 6
2006 8
2007 10
2008 9
2009 6
2010 3
2011 8
2012 9
2013 5
2014 7
2015 5
2016 8
2017 6
2018 11
2019 11
2020 11
2021 17
2022 10
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Sjögren's syndrome.
André F, Böckle BC. André F, et al. J Dtsch Dermatol Ges. 2022 Jul;20(7):980-1002. doi: 10.1111/ddg.14823. Epub 2022 Jul 1. J Dtsch Dermatol Ges. 2022. PMID: 35775593 Free PMC article.
Xerosis cutis and pruritus are the most common skin manifestations, followed by leukocytoclastic vasculitis and subacute cutaneous lupus erythematosus. In addition, SjS patients often have myoarthralgia and neuropsychiatric symptoms. ...
Xerosis cutis and pruritus are the most common skin manifestations, followed by leukocytoclastic vasculitis and subacute cutaneous …
Annular Lesions: Diagnosis and Treatment.
Trayes KP, Savage K, Studdiford JS. Trayes KP, et al. Am Fam Physician. 2018 Sep 1;98(5):283-291. Am Fam Physician. 2018. PMID: 30216021 Free article. Review.
Annular lesions occur less commonly in persons with fixed drug eruptions, leprosy, immunoglobulin A vasculitis, secondary syphilis, sarcoidosis, subacute cutaneous lupus erythematosus, and granuloma annulare....
Annular lesions occur less commonly in persons with fixed drug eruptions, leprosy, immunoglobulin A vasculitis, secondary syphilis, sarcoido …
Mimics of Dermatitis.
Bailiff OA, Mowad CM. Bailiff OA, et al. Immunol Allergy Clin North Am. 2021 Aug;41(3):493-515. doi: 10.1016/j.iac.2021.04.009. Immunol Allergy Clin North Am. 2021. PMID: 34225903 Review.
Annular lichenoid diseases.
McNally MA, Farooq S, Brown AE, Rees A, Hsu S, Motaparthi K. McNally MA, et al. Clin Dermatol. 2022 Sep-Oct;40(5):466-479. doi: 10.1016/j.clindermatol.2021.12.009. Epub 2021 Dec 31. Clin Dermatol. 2022. PMID: 34979268
Examples include annular lichenoid dermatitis of youth, annular lichen planus, erythema dyschromicum perstans, erythema multiforme, fixed drug eruption, lichen sclerosus, neonatal lupus, porokeratosis, subacute cutaneous lupus erythematosus, and lichen …
Examples include annular lichenoid dermatitis of youth, annular lichen planus, erythema dyschromicum perstans, erythema multiforme, fixed dr …
Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
Foulke G, Helm LA, Clebak KT, Helm M. Foulke G, et al. FP Essent. 2023 Mar;526:25-36. FP Essent. 2023. PMID: 36913660
Lupus-specific skin conditions include acute cutaneous lupus erythematosus (ACLE) which manifests as a malar or butterfly rash; subacute cutaneous lupus erythematosus (SCLE); and chronic cutaneous lupus erythematosus, which includes discoid lupus eryth …
Lupus-specific skin conditions include acute cutaneous lupus erythematosus (ACLE) which manifests as a malar or butterfly rash; subacute …
Subacute cutaneous lupus erythematosus: A facultative paraneoplastic dermatosis.
Lazar AL. Lazar AL. Clin Dermatol. 2022 Nov-Dec;40(6):728-742. doi: 10.1016/j.clindermatol.2022.07.007. Epub 2022 Jul 28. Clin Dermatol. 2022. PMID: 35907579 Review.
Subacute cutaneous lupus erythematosus (SCLE) is a photosensitive dermatosis characterized by a nonscarring papulosquamous eruption and specific antibodies in the patient's serum. ...
Subacute cutaneous lupus erythematosus (SCLE) is a photosensitive dermatosis characterized by a nonscarring papu …
Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.
Moura Filho JP, Peixoto RL, Martins LG, Melo SD, Carvalho LL, Pereira AK, Freire EA. Moura Filho JP, et al. An Bras Dermatol. 2014 Jan-Feb;89(1):118-25. doi: 10.1590/abd1806-4841.20142146. An Bras Dermatol. 2014. PMID: 24626656 Free PMC article. Review.
Depending on their clinical characteristics, they can be classified into Acute Cutaneous Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus and Intermittent Cutaneous Lupus Erythematosus. ...
Depending on their clinical characteristics, they can be classified into Acute Cutaneous Lupus Erythematosus, Subacute Cutaneous …
Subacute cutaneous lupus erythematosus.
Furzeland J, Malcolm P. Furzeland J, et al. J R Army Med Corps. 2017 Apr;163(2):149-151. doi: 10.1136/jramc-2015-000566. Epub 2016 Jun 9. J R Army Med Corps. 2017. PMID: 27286780
A 31-year-old female soldier developed subacute cutaneous lupus erythematosus, which remained undiagnosed for 4 years. ...
A 31-year-old female soldier developed subacute cutaneous lupus erythematosus, which remained undiagnosed for 4 …
Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.
Heinly B, Allenzara A, Helm M, Foulke GT. Heinly B, et al. Drugs Aging. 2024 Jan;41(1):31-43. doi: 10.1007/s40266-023-01079-5. Epub 2023 Nov 22. Drugs Aging. 2024. PMID: 37991658 Review.
It is thought that most CLE in older populations is drug-induced, with drug-induced subacute cutaneous lupus erythematosus being the most common subtype. ...
It is thought that most CLE in older populations is drug-induced, with drug-induced subacute cutaneous lupus erythem …
Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
Poh YJ, Alrashid A, Sangle SR, Higgins E, Benton E, McGibbon D, D'Cruz DP. Poh YJ, et al. Lupus. 2022 Aug;31(9):1078-1083. doi: 10.1177/09612033221104237. Epub 2022 May 30. Lupus. 2022. PMID: 35635045
BACKGROUND: There is a growing literature reporting the association between proton pump inhibitor (PPI) use and subacute cutaneous lupus erythematosus (SCLE). AIMS: To compare the clinical characteristics of a cohort of patients with PPI-induced SCLE, …
BACKGROUND: There is a growing literature reporting the association between proton pump inhibitor (PPI) use and subacute cutaneous …
223 results